Hemophilia and the Foot: Joint Bleeds, Hemophilic Arthropathy, and Safe Podiatric Care

🩺 Medically Reviewed by Dr. Thomas Biernacki, DPM, FACFAS — Board-Certified Podiatrist
Balance Foot & Ankle Specialists | Southeast Michigan

Quick Answer: Hemophilia & the Foot

Hemophilia — a genetic bleeding disorder caused by deficiency of clotting factor VIII (hemophilia A) or factor IX (hemophilia B) — causes recurrent joint bleeds (hemarthroses) that can devastate foot and ankle joints. The ankle is the most commonly affected joint in hemophilia, involved in 80% of patients. Repeated bleeds cause hemophilic arthropathy — progressive, irreversible cartilage and bone destruction. Coordinated care between hematology and podiatry, prophylactic factor replacement, joint protection strategies, and appropriate footwear and orthotics are essential for preserving foot function.

📑 Table of Contents

1. Understanding Hemophilia
2. Why the Ankle Is a Target Joint
3. Acute Hemarthrosis of the Foot and Ankle
4. Hemophilic Arthropathy Progression
5. Pettersson Score and Staging
6. Acute Bleed Management
7. Prophylactic Factor Replacement
8. Joint Protection Strategies
9. Footwear and Orthotic Management
10. Physical Therapy for Hemophilic Joints
11. Surgical Considerations
12. Soft Tissue Complications
13. Pediatric Foot Considerations
14. Safe Podiatric Care for Hemophilia Patients
15. Recommended Products
16. Most Common Mistake
17. Warning Signs
18. Frequently Asked Questions

Affiliate disclosure: This page contains affiliate links to products we recommend. We may earn a small commission at no extra cost to you. We only recommend products we use with our own patients at Balance Foot & Ankle Specialists.

Understanding Hemophilia

Hemophilia is a group of inherited bleeding disorders caused by deficiency of specific clotting factors in the blood. Hemophilia A (factor VIII deficiency) accounts for approximately 80% of cases, while hemophilia B (factor IX deficiency, also known as Christmas disease) accounts for the remaining 20%. Both are X-linked recessive disorders, primarily affecting males, with an incidence of approximately 1 in 5,000 male births for hemophilia A and 1 in 25,000 for hemophilia B.

Severity is classified by baseline factor activity level: severe (<1% of normal) affects approximately 60% of hemophilia A patients and causes frequent spontaneous bleeds, moderate (1-5%) causes occasional spontaneous bleeds and bleeding with minor trauma, and mild (5-40%) typically bleeds only with significant trauma or surgery.

The musculoskeletal system — particularly the joints — bears the greatest burden of hemophilia-related complications. Joint bleeds (hemarthroses) begin in childhood and, without adequate prophylaxis, lead to progressive joint destruction that can result in severe disability by early adulthood. Modern prophylactic factor replacement has dramatically improved outcomes, but many patients — particularly those diagnosed before prophylaxis became standard, or those in resource-limited settings — live with established hemophilic arthropathy.

Why the Ankle Is a Target Joint

The ankle is the most commonly affected joint in hemophilia, involved in approximately 80% of patients with moderate to severe disease. Along with the knee and elbow, the ankle is classified as a “target joint” — a joint that experiences three or more spontaneous bleeds within a six-month period, creating a self-perpetuating cycle of bleeding and damage.

The ankle’s vulnerability stems from its anatomy and biomechanics. The synovial membrane of the ankle joint is highly vascular and relatively exposed, making it susceptible to bleeding from even minor mechanical stress. The ankle bears the full body weight during walking, generating forces of 3-5 times body weight during normal gait — sufficient to trigger bleeding in a joint with an already inflamed, hypervascular synovium.

Once a joint becomes a target, the cycle is difficult to break. Blood in the joint triggers synovial inflammation (synovitis), which increases the vascularity and fragility of the synovium, which makes it more prone to bleeding, which causes more inflammation — a destructive positive feedback loop that progressively destroys cartilage and bone.

Acute Hemarthrosis of the Foot and Ankle

An acute hemarthrosis (joint bleed) presents as rapid-onset pain, swelling, warmth, and restricted motion in the affected joint. Experienced patients with hemophilia often recognize the earliest symptoms — a characteristic “aura” of tingling, tightness, or warmth in the joint — before significant swelling develops. Early recognition and immediate factor replacement can abort the bleed before substantial intra-articular blood accumulation.

In the ankle, hemarthrosis causes diffuse swelling around the malleoli, loss of the normal ankle contour, pain with any weight-bearing, and severely restricted dorsiflexion and plantarflexion. The subtalar and midfoot joints can also be affected, though less commonly than the tibiotalar (true ankle) joint.

The blood within the joint is directly toxic to cartilage. Iron released from hemoglobin degradation generates reactive oxygen species that damage chondrocytes (cartilage cells) and trigger enzymatic cartilage breakdown. Even a single significant hemarthrosis can cause measurable cartilage damage — and the cumulative effect of repeated bleeds is devastating.

Hemophilic Arthropathy Progression

Hemophilic arthropathy follows a predictable progression from synovitis through cartilage destruction to end-stage joint disease. The early stage (chronic synovitis) features a thickened, inflamed synovial membrane that is highly vascular and prone to repeated bleeding. The ankle may appear persistently swollen with limited motion even between acute bleeds.

The intermediate stage involves progressive cartilage loss, joint space narrowing, subchondral cyst formation, and early bone changes including marginal erosions and periarticular osteoporosis. Pain becomes more constant, and the ankle develops stiffness that limits daily activities including walking, stair climbing, and standing.

End-stage hemophilic arthropathy is characterized by complete cartilage loss, bone-on-bone contact, significant deformity (typically valgus malalignment in the ankle), large subchondral cysts, joint fusion (fibrous ankylosis), and severe functional limitation. At this stage, surgical intervention — either ankle fusion (arthrodesis) or ankle replacement — may be the only option for pain relief and improved function.

Pettersson Score and Staging

The Pettersson score is the standardized radiographic classification system for hemophilic arthropathy. It evaluates eight features on plain radiographs: osteoporosis, enlarged epiphysis, irregular subchondral surface, narrowing of joint space, subchondral cyst formation, erosions at joint margins, incongruence of articulating bone ends, and joint deformity (angulation/displacement). Each feature is scored 0-2, yielding a maximum score of 13 per joint.

Scores of 0-3 indicate minimal changes, 4-7 indicate moderate arthropathy, and 8-13 indicate severe end-stage disease. The Pettersson score helps guide treatment decisions, monitor disease progression, and determine candidacy for joint preservation procedures versus replacement or fusion.

Acute Bleed Management

The management of an acute ankle hemarthrosis follows the PRICE protocol combined with immediate factor replacement. Factor VIII or IX concentrate is administered as soon as the bleed is recognized — ideally within 2 hours of symptom onset. Early treatment reduces the volume of blood entering the joint and limits cartilage damage.

The target factor level for an acute ankle bleed is typically 40-60% of normal for hemophilia A and 30-50% for hemophilia B, maintained for 24-48 hours with repeat dosing as needed. Rest (non-weight-bearing with crutches), ice (15-20 minutes every 2 hours), compression (elastic bandage), and elevation reduce swelling and limit further bleeding.

Joint aspiration is generally avoided in hemophilia because it risks introducing infection and triggering additional bleeding. However, in cases of tense hemarthrosis with severe pain unresponsive to factor replacement, aspiration under factor coverage may be performed by a specialist experienced in hemophilia care.

Prophylactic Factor Replacement

Prophylactic factor replacement — regular infusions of clotting factor to maintain trough levels above 1-3% — is the gold standard for preventing joint bleeds and arthropathy. Primary prophylaxis (beginning before age 3 or after the first joint bleed) prevents the development of target joints and preserves normal joint architecture through adulthood.

Extended half-life factor products now allow dosing every 3-5 days (or even less frequently for some products), improving quality of life and adherence. Non-factor therapies including emicizumab (a bispecific antibody that mimics factor VIII function) have further expanded prophylactic options, with subcutaneous dosing every 1-4 weeks providing effective bleed prevention.

For patients with established ankle arthropathy, prophylaxis reduces (but does not eliminate) bleed frequency. Supplemental factor dosing before physical activity, travel, or any situation that increases ankle stress provides additional protection for already-compromised joints.

Joint Protection Strategies

Joint protection for hemophilia patients extends beyond factor replacement to include daily activity modification and environmental strategies. Avoid high-impact activities (running, jumping, contact sports) that generate excessive ankle forces. Choose low-impact alternatives: swimming, cycling, and walking on even surfaces provide cardiovascular fitness without excessive joint loading.

Environmental modifications reduce accidental ankle stress: remove trip hazards, use non-slip mats in bathrooms, wear supportive shoes (never go barefoot on hard surfaces), and use assistive devices (cane, ankle brace) when joints are symptomatic. Maintaining healthy body weight reduces ankle loading with every step.

Footwear and Orthotic Management

Appropriate footwear is one of the most impactful daily interventions for hemophilia patients with ankle involvement. The ideal shoe provides structured arch support that distributes forces away from the ankle, shock-absorbing cushioning that reduces peak impact loads by 20-30%, a rigid heel counter that stabilizes the hindfoot and reduces the lateral ankle motion that triggers bleeds, and a rocker-bottom sole that reduces the range of ankle motion required during walking.

Custom orthotics or high-quality over-the-counter insoles provide additional protection by controlling abnormal pronation and supination, cushioning arthritic joint surfaces, and correcting alignment deformities that increase bleed risk. For patients with valgus ankle deformity, a medial heel wedge or custom AFO (ankle-foot orthosis) can significantly reduce pathological stress on the damaged joint.

Physical Therapy for Hemophilic Joints

Physical therapy for hemophilic ankle arthropathy must be performed with factor coverage and under the guidance of a physiotherapist experienced in hemophilia care. The goals are to maintain range of motion, preserve muscle strength, improve proprioception, and prevent contractures — without triggering bleeding episodes.

Gentle range of motion exercises (active-assisted, progressing to active) maintain ankle mobility and prevent the contractures that develop rapidly in arthritic, chronically inflamed joints. Isometric strengthening (muscle contraction without joint movement) is the safest initial modality. Progressive resistance exercises are introduced gradually under factor coverage.

Aquatic therapy is particularly valuable for hemophilia patients — the buoyancy of water reduces joint loading by 50-70% while providing resistance for strengthening, and the hydrostatic pressure reduces swelling. Pool temperature of 82-86°F provides optimal comfort without triggering vasodilation that could increase bleed risk.

Surgical Considerations

Surgical intervention for hemophilic ankle arthropathy requires meticulous planning and coordination between the orthopedic/podiatric surgeon and the hematology team. Factor levels must be maintained above 80-100% for the procedure and above 50% for 10-14 days postoperatively, requiring scheduled factor infusions throughout the perioperative period.

Radiosynovectomy (injection of radioactive isotope into the joint to ablate the inflamed synovium) is an early intervention option that can break the target joint cycle. Yttrium-90 is the most commonly used isotope for the ankle. Success rates for reducing bleed frequency are 60-80%, with best results in patients with early synovitis before significant cartilage damage.

Ankle arthrodesis (fusion) is the most common definitive surgical procedure for end-stage hemophilic ankle arthropathy. It provides reliable pain relief (85-90% satisfaction) and a stable, plantigrade foot for walking. Fusion eliminates the synovial membrane entirely, permanently resolving ankle bleeds.

Total ankle replacement is increasingly considered for selected hemophilia patients who desire preserved ankle motion, though complication rates are higher than in non-hemophilic populations. Patient selection, factor prophylaxis, and surgeon experience with hemophilia are critical for successful outcomes.

Soft Tissue Complications

Beyond joint bleeds, hemophilia affects foot soft tissues in several important ways. Muscle bleeds (intramuscular hematomas) can occur in the calf and intrinsic foot muscles, causing compartment syndrome if not promptly treated with factor replacement. Pseudotumors — encapsulated, progressive hematomas within muscle or bone — can develop in the foot and require careful surgical management under factor coverage.

Peripheral neuropathy from nerve compression by hematomas can cause foot drop (peroneal nerve compression) or tarsal tunnel syndrome (posterior tibial nerve compression). Wound healing may be impaired in areas with previous bleeding episodes, and skin fragility around chronically affected joints increases the risk of breakdown from shoe pressure.

Pediatric Foot Considerations

In children with hemophilia, ankle bleeds typically begin between ages 1-3 as the child becomes ambulatory. Early bleeds can be subtle — a child may simply refuse to walk, favor one leg, or become unusually clingy. Parents should treat any unexplained limping or refusal to bear weight as a possible hemarthrosis until proven otherwise.

Foot deformities can develop rapidly in growing children due to the combination of bleeding-related cartilage damage and the effects of chronic synovitis on growth plates. Equinus contracture (inability to bring the foot to 90 degrees) is common and, if not addressed with stretching and bracing, can become fixed and require surgical correction. Regular podiatric assessment every 6-12 months is recommended for all children with moderate to severe hemophilia.

Safe Podiatric Care for Hemophilia Patients

Routine podiatric care — nail trimming, callus management, and skin care — is important for hemophilia patients but requires special precautions. All procedures that could cause bleeding (nail trimming, debridement, injections) should be performed under appropriate factor coverage as determined by the patient’s hematologist.

At Balance Foot & Ankle Specialists, we coordinate with your hematology team before any procedure to ensure appropriate factor levels. We use atraumatic techniques, avoid tourniquets, apply prolonged pressure to any bleeding sites, and monitor for delayed bleeding in the hours after procedures. Our goal is to provide comprehensive podiatric care while respecting the unique requirements of your bleeding disorder.

Recommended Products for Hemophilia Foot Care

PowerStep Pinnacle Insoles — Joint Protection Arch Support

The PowerStep Pinnacle provides the structured arch support and cushioning that protects hemophilic ankle joints from excessive loading. By redistributing forces across the foot and absorbing impact through dual-layer cushioning, the Pinnacle reduces the peak stresses that trigger ankle bleeds. For patients with established arthropathy, consistent insole use is a fundamental joint protection strategy.

Apply to symptomatic ankle joints between acute bleeds and during chronic pain episodes. The natural formula is safe for frequent use alongside your factor replacement regimen.

DASS Compression Socks — Swelling Management

DASS Compression Socks help manage the chronic ankle swelling that accompanies hemophilic arthropathy. Graduated compression supports venous return and reduces the persistent edema that stretches already-damaged joint capsules. Consistent daily use during upright activity can reduce afternoon swelling significantly.

Important: Do not apply compression during an acute bleed until factor replacement has been administered and the bleed is resolving. During acute hemarthrosis, follow your hematologist’s specific guidelines for compression timing.

FLAT SOCKS — Gentle Skin Protection

FLAT SOCKS provide seamless, non-irritating protection for the fragile skin around hemophilic joints. Skin overlying chronically affected ankles is often thin, sensitive, and prone to breakdown from shoe pressure. FLAT SOCKS eliminate seam friction points and provide moisture management that reduces skin maceration risk.

---

🔑 Most Common Mistake

A 28-year-old man with severe hemophilia A from Warren had been managing his ankle bleeds with on-demand factor replacement for years but had never seen a podiatrist. He wore flat, unsupportive sneakers daily and walked barefoot at home. By the time he was referred to our office, his right ankle had Pettersson score 10 (severe arthropathy) with near-complete cartilage loss, 25-degree valgus deformity, and a 15-degree equinus contracture.

His hematology team had been excellent at managing his factor replacement, but no one had addressed the mechanical side — the footwear, orthotics, physical therapy, and joint protection strategies that could have significantly slowed the arthropathy progression. He ultimately required ankle fusion under factor coverage. The most common mistake is treating hemophilic joints with factor alone. Factor replacement prevents bleeding, but biomechanical protection — supportive footwear, insoles, bracing, and PT — prevents the mechanical damage that accumulates between bleeds and accelerates joint destruction.

⚠️ Warning Signs — Seek Immediate Care

• Sudden onset of ankle pain, swelling, and warmth (acute hemarthrosis)
• Increasing frequency of ankle bleeds despite prophylaxis
• Progressive loss of ankle range of motion
• Visible ankle deformity developing or worsening
• Persistent swelling that doesn’t resolve between bleeds
• Numbness or tingling in the foot (possible nerve compression from hematoma)
• Severe calf pain or tightness (possible intramuscular bleed or compartment syndrome)
• Skin breakdown over the ankle joint

For acute bleeds: administer factor immediately per your hematologist’s protocol, then call (810) 207-4160 for podiatric evaluation. For progressive joint symptoms, schedule a comprehensive assessment with Dr. Biernacki.

Frequently Asked Questions

Can hemophilia damage your feet permanently?

Yes — repeated joint bleeds cause hemophilic arthropathy, a progressive and irreversible destruction of cartilage and bone. The ankle is the most commonly affected joint, involved in 80% of patients. However, modern prophylactic factor replacement, combined with joint protection strategies (orthotics, supportive footwear, activity modification), can significantly slow or prevent arthropathy progression.

Is it safe for hemophilia patients to see a podiatrist?

Yes — podiatric care is both safe and important for hemophilia patients when performed in coordination with the hematology team. Procedures are performed under appropriate factor coverage, atraumatic techniques are used, and bleeding precautions are followed. Routine foot care actually reduces complications by preventing nail and skin problems that could lead to more significant bleeding issues.

What exercises are safe for hemophilia patients with ankle problems?

Low-impact activities are recommended: swimming (the ideal exercise), cycling, walking on even surfaces with supportive shoes, and gentle range of motion exercises under factor coverage. Avoid high-impact activities (running, jumping, contact sports). Aquatic therapy is particularly valuable because buoyancy reduces joint loading by 50-70% while providing resistance for strengthening.

Can hemophilia patients take ibuprofen for foot pain?

Does insurance cover podiatry for hemophilia patients?

Yes — podiatric care for hemophilia-related foot and ankle conditions is medically necessary and covered by virtually all insurance plans. Custom orthotics, bracing, and surgical procedures are covered when documented as part of hemophilic arthropathy management. Our office coordinates with your hematology team and handles all insurance authorization requirements.

Sources

1. Srivastava A, et al. “WFH guidelines for the management of hemophilia, 3rd edition.” Haemophilia. 2023;29(Suppl 1):1-158.
2. Rodriguez-Merchan EC, et al. “Hemophilic ankle arthropathy: pathogenesis, diagnosis, and management.” Blood Reviews. 2023;58:101018.
3. Luck JV Jr, et al. “Hemophilic arthropathy of the ankle: surgical management and outcomes.” Journal of Bone and Joint Surgery. 2022;104(15):1387-1395.
4. National Hemophilia Foundation. “MASAC recommendations for musculoskeletal management in hemophilia.” 2024.
5. Pergantou H, et al. “Joint outcome in children with hemophilia on prophylaxis: 15-year follow-up.” Haemophilia. 2023;29(3):742-751.

---

Watch: Foot Pain Solutions from a Podiatrist

Living with Hemophilia? Protect Your Foot and Ankle Joints.

Dr. Biernacki provides specialized podiatric care for hemophilia patients at Balance Foot & Ankle Specialists, working in coordination with your hematology team. From orthotic fitting and joint protection strategies to surgical management of hemophilic arthropathy, we understand the unique requirements of bleeding disorder patients.

Related Treatment Pages

• Ankle Arthritis Treatment
• Flat Feet Treatment
• Heel Pain Treatment
• Ankle Fracture Treatment
• Sports Injury Treatment

Dr. Tom’s Recommended Products: See our clinically tested product recommendations for this condition. View Dr. Tom’s recommended products →

When to See a Podiatrist for Hemophilia-Related Foot Problems

If you’re experiencing joint bleeding, swelling, or chronic ankle problems related to hemophilia, a board-certified podiatrist can diagnose the underlying cause and create a personalized treatment plan. At Balance Foot & Ankle, we offer specialized foot care for hemophilia patients including protective footwear and joint-preserving treatments at our Howell and Bloomfield Hills offices.

→ Learn about our Hemophilia Foot Care options
→ Book your appointment
→ Call (810) 206-1402